Hydrogel-Driven Drug Dosage Form
First Claim
Patent Images
1. A controlled release drug dosage form comprising a core and a coating around said core wherein:
- (a) said core comprises a drug-containing composition and a water-swellable composition, each occupying separate regions within said core;
(b) said drug-containing composition comprises a drug, a swelling agent, and a drug-entraining agent;
(c) said coating is water-permeable, water-insoluble, and has at least one delivery port therethrough;
(d) said swelling agent has a swelling ratio of at least 3.5; and
(e) said drug-entraining agent comprises at least 15 wt % of said drug-containing composition.
5 Assignments
0 Petitions
Accused Products
Abstract
A controlled release dosage form has a coated core with the core comprising a drug-containing composition and a water-swellable composition, each occupying separate regions within the core. The drug-containing composition comprises a low-solubility drug and a drug-entraining agent. The coating around the core is water-permeable, water-insoluble and has at least one delivery port therethrough. A variety of formulations having specific drug release profiles are disclosed.
-
Citations
131 Claims
-
1. A controlled release drug dosage form comprising a core and a coating around said core wherein:
-
(a) said core comprises a drug-containing composition and a water-swellable composition, each occupying separate regions within said core;
(b) said drug-containing composition comprises a drug, a swelling agent, and a drug-entraining agent;
(c) said coating is water-permeable, water-insoluble, and has at least one delivery port therethrough;
(d) said swelling agent has a swelling ratio of at least 3.5; and
(e) said drug-entraining agent comprises at least 15 wt % of said drug-containing composition. - View Dependent Claims (7, 8, 9, 10, 11, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 40, 41, 42, 43, 46, 52, 53, 54, 55, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 101, 103, 104, 105, 106, 107, 108, 118, 123, 130)
-
-
2. A controlled release drug dosage form comprising a core and a coating around said core wherein:
-
(a) said core comprises a drug-containing composition and a water-swellable composition, each occupying separate regions within said core;
(b) said drug-containing composition comprises a drug and a drug-entraining agent;
(c) said water-swellable composition comprises a swelling agent and a tableting aid;
(d) said coating is water-permeable, water-insoluble, and has at least one delivery port therethrough;
(e) the mass ratio of said drug-containing composition to said water-swellable composition has a value of at least 1.5;
(f) said water-swellable composition has a swelling ratio of at least 3.5; and
(g) said core has a strength following tableting of at least 3 Kp/cm2. - View Dependent Claims (12, 44, 45, 47, 48, 49, 50, 51, 56, 124)
-
-
3. A controlled release drug dosage form comprising a core and a coating around said core wherein:
-
(a) said core comprises a drug-containing composition and a water-swellable composition, each occupying separate regions within said core;
(b) said drug-containing composition comprises a drug and a drug-entraining agent; and
(c) said coating is water-permeable, water-insoluble, has at least one delivery port therethrough, has a water flux (40/75) of at least 1.0×
10−
3 gm/cm2·
hr, and a durability of at least 1 Kp/cm2. - View Dependent Claims (125)
-
-
4. A controlled release dosage form comprising a core and a coating around said core wherein:
-
(a) said core comprises a drug-containing composition and a water-swellable composition, each occupying separate regions within said core;
(b) said drug-containing composition comprises a drug and a drug-entraining agent; and
(c) said coating is water-permeable, water-insoluble, has at least one delivery port therethrough, is porous and is formed from a substantially homogeneous solution comprising a solvent, a cellulosic polymer, and a non-solvent. - View Dependent Claims (82, 83, 84, 85, 86, 87, 98, 99, 100, 102, 109, 110, 111, 112, 114, 115, 116, 117, 119, 120, 121, 122, 126, 129, 131)
-
-
5. A controlled release drug dosage form comprising a core and a coating around said core wherein:
-
(a) said core comprises a drug-containing composition and a water-swellable composition, each occupying separate regions within said core;
(b) said drug-containing composition comprises a drug, a drug-entraining agent, and a fluidizing agent, said fluidizing agent having a solubility of at least 30 mg/mL and comprising at least 10 wt % of said drug-containing composition; and
(c) said coating is water-permeable, water-insoluble, and has at least one delivery port therethrough, wherein at least about 70 wt % of said low-solubility drug is released to a use environment within about 12 hours after introduction to said use environment. - View Dependent Claims (33, 34, 35, 36, 37, 38, 39, 127)
-
-
6. A controlled release dosage form comprising a core and a coating around said core wherein:
-
(a) said core comprises a drug-containing composition and a water-swellable composition, each occupying separate regions within said core;
(b) said drug-containing composition comprises a drug, a solubilizer, and a drug-entraining agent; and
(c) said coating is water-permeable, water-insoluble, and has at least one delivery port therethrough. - View Dependent Claims (128)
-
-
113. A controlled release dosage form comprising a core and a coating around said core wherein:
-
(a) said core comprises a drug-containing composition and a water-swellable composition, each occupying separate regions within said core;
(b) said drug-containing composition comprises a low-solubility drug and a drug-entraining agent; and
(c) said coating is water-permeable, water-insoluble, and has at least one delivery port therethrough; and
(d) wherein said low-solubility drug is in the form of an amorphous dispersion.
-
Specification